Lv4
732 积分 2024-04-22 加入
Biomarkers for immunotherapy of hepatocellular carcinoma
6天前
已完结
Immunotherapy at all stages of hepatocellular carcinoma
4个月前
已完结
Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma
4个月前
已完结
Targeting GSDME-mediated macrophage polarization for enhanced antitumor immunity in hepatocellular carcinoma
4个月前
已完结
Targeting GSDME-mediated macrophage polarization for enhanced antitumor immunity in hepatocellular carcinoma
4个月前
已完结
[Chinese expert consensus on neoadjuvant therapy for hepatocellular carcinoma (2023 edition)]
4个月前
已完结
The hallmarks of cancer immune evasion
4个月前
已完结
Disruption of SLFN11 Deficiency–Induced CCL2 Signaling and Macrophage M2 Polarization Potentiates Anti–PD-1 Therapy Efficacy in Hepatocellular Carcinoma
5个月前
已完结
TGF-β1 Induced SOX18 Elevation Promotes Hepatocellular Carcinoma Progression and Metastasis through Transcriptionally Upregulating PD-L1 and CXCL12
5个月前
已完结
Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapy
6个月前
已完结
皖公网安备34019202002308
